ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
27.45
+0.86 (3.23%)
Nov 22, 2024, 4:00 PM EST - Market closed
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $924.99 million as of November 22, 2024.
Market Cap
924.99M
Enterprise Value
642.35M
1-Year Change
n/a
Ranking
Category
Stock Price
$27.45
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $924.99M, an increase of 60.81%. That is a compound annual growth rate of 78.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 923.64M | 60.57% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 942.24M |
| Nuvation Bio | 908.73M |
| Immatics | 904.72M |
| Paragon 28 | 873.20M |
| Liquidia | 859.06M |
| Healthcare Services Group | 844.31M |
| Cytek Biosciences | 832.12M |
| Evolus | 825.71M |